HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Circulating renalase, catecholamines, and vascular adhesion protein 1 in hypertensive patients.

Abstract
The aim of the study was to estimate and correlate circulating levels of renalase, vascular adhesion protein-1 (VAP-1), catecholamines in patients with primary hypertension. The renalase, VAP-1, and catecholamines concentration was estimated in 121 hypertensive patients. The correlation between renalase, VAP-1 levels and catecholamine concentration in blood, blood pressure control, pharmacological therapy, and medical history were taken in to consideration. The median office blood pressure was 145.5/86 mm Hg and was significantly higher than the median home blood pressure measurement value, which was 135/80 mm Hg, P < .05. Circulating renalase and VAP-1 (Me 9.57 μg/mL and Me = 326.7 ng/mL) levels were significantly higher in patients with hypertension comparing to healthy individuals (3.83 μg/mL and 248.37 ng/mL, P < .05). The correlation between renalase and noradrenalin concentration in blood was observed (r = 0.549; P < .05), also the correlation between VAP-1 and noradrenaline was noticed (r = 0.21, P = .029). Renalase level was higher in patients with coronary artery disease and correlated with decreased ejection fraction. VAP-1 concentration correlated also with left ventricular ejection fraction (r = -0.23, P = .013). Hypertensive patients with diabetes mellitus had almost statistically significant higher VAP-1 concentration compared with hypertensive patients without diabetes mellitus (Me = 403.22 ng/mL vs. Me = 326,68 ng/mL, P = .064). In multiple regression analysis, renalase was predicted by plasma dopamine and norepinephrine as also diastolic office blood pressure and left ventricle ejection fraction. Circulating renalase and VAP-1 levels are elevated in patients with poor blood pressure control. Its correlation with noradrenalin concentration need further studies to find out the role of renalase as also VAP-1 in pathogenesis and treatment of hypertension.
AuthorsDominika Maciorkowska, Edyta Zbroch, Jolanta Malyszko
JournalJournal of the American Society of Hypertension : JASH (J Am Soc Hypertens) Vol. 9 Issue 11 Pg. 855-64 (Nov 2015) ISSN: 1878-7436 [Electronic] United States
PMID26403854 (Publication Type: Comparative Study, Journal Article)
CopyrightCopyright © 2015 American Society of Hypertension. Published by Elsevier Inc. All rights reserved.
Chemical References
  • Antihypertensive Agents
  • Biomarkers
  • Catecholamines
  • Cell Adhesion Molecules
  • AOC3 protein, human
  • Amine Oxidase (Copper-Containing)
  • Monoamine Oxidase
  • renalase
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Amine Oxidase (Copper-Containing) (blood)
  • Antihypertensive Agents (therapeutic use)
  • Biomarkers (blood)
  • Blood Pressure Determination
  • Catecholamines (blood)
  • Cell Adhesion Molecules (blood)
  • Essential Hypertension
  • Female
  • Humans
  • Hypertension (blood, diagnosis, drug therapy)
  • Male
  • Middle Aged
  • Monoamine Oxidase (blood)
  • Poland
  • Predictive Value of Tests
  • Prognosis
  • Regression Analysis
  • Risk Assessment
  • Severity of Illness Index
  • Treatment Outcome
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: